Aclarion, Inc.

Name: Aclarion, Inc. standardized financial statements, quarterly
Creator: Listed

ACONNasdaqCIK 1635077HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$25.2k, Q2 FY2026

Operating income−$2.9m, Q2 FY2026

Net income−$2.7m, Q2 FY2026

Aclarion, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	19.1	13.8	10.1	11.0	14.4	10.2	19.0	19.3	18.9	18.5	21.1	25.2
Cost of revenue	$k	19.6	19.4	19.5	23.3	21.3	20.6	23.5	14.2	14.6	16.7	17.4	16.9
Gross profit	$k	(0.5)	(5.6)	(9.4)	(12.3)	(6.9)	(10.3)	(4.5)	5.1	4.4	1.8	3.8	8.3
Research and development	$k	198	221	239	202	196	252	198	270	302	263	315	297
Operating income	$k	(1,162)	(1,126)	(1,275)	(1,136)	(1,296)	(1,806)	(1,492)	(1,737)	(1,831)	(1,993)	(2,987)	(2,900)
Interest expense	$k	166	(104)	336	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$k	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$k	(998)	(1,265)	(2,399)	(1,238)	(1,366)	(1,990)	(2,037)	(1,601)	(1,706)	(1,889)	(2,854)	(2,748)
Diluted EPS	$ per share	(1.87)	not reported	(3985.22)	(1362.83)	(1321.49)	not reported	(9.32)	(2.75)	(2.93)	not reported	(1.34)	(1.12)
Basic EPS	$ per share	(1.87)	not reported	(3985.22)	(1362.83)	(1321.49)	not reported	(9.32)	(2.75)	(2.93)	not reported	(1.34)	(1.12)

Balance sheet

Cash and equivalents$16.3m, Q2 FY2026

Shareholders' equity$17.0m, Q2 FY2026

Aclarion, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.2	1.0	2.1	1.2	1.3	0.5	14.8	12.8	11.3	12.0	19.0	16.3
Current assets	$m	0.4	1.3	2.5	1.9	1.9	0.8	15.2	13.4	11.9	12.4	19.4	16.8
Total assets	$m	1.5	2.5	3.7	3.1	3.2	2.1	16.5	14.8	13.2	13.7	20.6	18.0
Current liabilities	$m	2.4	3.2	1.2	1.4	0.7	1.2	0.7	0.6	0.7	0.8	1.0	1.0
Total liabilities	$m	not reported	3.2	1.2	1.4	0.7	1.2	0.7	0.6	0.7	0.8	1.0	1.0
Shareholders' equity	$m	(0.8)	(0.7)	2.5	1.6	2.5	1.0	15.8	14.2	12.5	12.8	19.7	17.0

Cash flow

Operating cash flow−$2.7m, Q2 FY2026

Capital expenditure$13.7k, Q4 FY2025

Aclarion, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(953)	(734)	(2,239)	(1,055)	(1,056)	(923)	(2,511)	(1,866)	(1,160)	(1,627)	(2,642)	(2,657)
Capital expenditure	$k	not reported	not reported	not reported	not reported	0.0	5.1	not reported	not reported	7.3	13.7	not reported	not reported

Diluted shares (weighted)2.46m, Q2 FY2026

Aclarion, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	k shares	7,822	496	518	533	0.6	0.9	1.0	219	582	582	2,130	2,462

Shares outstanding: 2.88m at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.